61: Drug Resistant Thyroid Cancer, with Dr. Carmelo Nucera from Harvard Medical School

New treatment options that are proving effective

Carmelo Nucera, M.D., Ph.D.

is currently an Assistant Professor at Harvard Medical School, Boston, in the Division of Cancer Biology and Angiogenesis (Department of Pathology), Beth Israel Deaconess Medical Center. Dr. Nucera received his M.D. and Ph.D. in Experimental Endocrinology and Metabolism from Italy.  Dr. Nucera is highly driven by an intense desire to make important contributions that will directly benefit patients. Dr. Nucera is strongly committed to make discovery aimed to immediately cure patients that are suffering with aggressive tumors and rare/orphan cancer disease.
Dr. Nucera has a clinical background and intensely served patients with fatal human diseases.

In this episode, Dr. Nucera discusses a combination drug therapy using vemurafenib and palbociclib represents a novel therapeutic strategy to treat papillary thyroid carcinoma (PTC).

Share the episode

Facebook
Google+
Twitter
LinkedIn

NOTES

Thyroid Change Resources

Listen to Doctor Thyroid here!

Leave a Reply

Close Menu

Subscribe to Doctor Thyroid with Philip James Newsletter

No spam. Your information is safe.
It will not be shared with any third party.
You can unsubscribe at any time.